American Research & Management Company’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$43K Sell
155
-3
-2% -$844 0.01% 202
2022
Q2
$42K Buy
158
+150
+1,875% +$38.7K 0.01% 207
2022
Q1
$2K Hold
8
﹤0.01% 376
2021
Q4
$2K Hold
8
﹤0.01% 363
2021
Q3
$2K Hold
8
﹤0.01% 354
2021
Q2
$2K Hold
8
﹤0.01% 360
2021
Q1
$2K Sell
8
-10
-56% -$2.23K ﹤0.01% 346
2020
Q4
$4K Sell
18
-199
-92% -$39K ﹤0.01% 334
2020
Q3
$37K Hold
217
0.01% 199
2020
Q2
$41K Buy
217
+10
+5% +$1.9K 0.01% 193
2020
Q1
$37K Hold
207
0.01% 188
2019
Q4
$42K Hold
207
0.01% 196
2019
Q3
$31K Sell
207
-5
-2% -$814 0.01% 219
2019
Q2
$33K Hold
212
0.01% 228
2019
Q1
$34K Hold
212
0.01% 239
2018
Q4
$40K Buy
+212
New +$44.2K 0.01% 186

Other funds holding CI

American Research & Management Company's CI Position: Q3 2022 in Review

American Research & Management Company reduced its Cigna (CI) stake by 1.9% in Q3 2022, selling an estimated $844 and leaving 155 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #202.

American Research & Management Company first reported a position in CI in Q4 2018 and has held it in 16 quarters since. 1,483 funds tracked by Wall St. Rank hold CI as of Q3 2022.

  • American Research & Management Company held 155 shares of Cigna worth $43K as of Q3 2022.
  • American Research & Management Company sold 3 Cigna shares in Q3 2022, an estimated $844.
  • Cigna made up 0.01% of American Research & Management Company's portfolio in Q3 2022, its #202 holding.
  • American Research & Management Company first reported a position in Cigna in Q4 2018 and has held it in 16 quarters since.
  • 1,483 funds tracked by Wall St. Rank held Cigna as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.